Definitive Healthcare
123 hedge funds and large institutions have $1.69B invested in Definitive Healthcare in 2022 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 57 increasing their positions, 26 reducing their positions, and 20 closing their positions.
2,658% more call options, than puts
Call options by funds: $331K | Put options by funds: $12K
119% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 26
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
40% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 20
6% more funds holding
Funds holding: 116 → 123 (+7)
1.6% more ownership
Funds ownership: 106.69% → 108.29% (+1.6%)
29% less capital invested
Capital invested by funds: $2.39B → $1.69B (-$699M)
Top Buyers
| 1 |
FAM
Fred Alger Management
New York
|
+$36.7M |
| 2 |
Jennison Associates
New York
|
+$28.5M |
| 3 |
Norges Bank
Oslo,
Norway
|
+$11M |
| 4 |
ECM
Element Capital Management
New York
|
+$8.66M |
| 5 |
JP Morgan Chase
New York
|
+$5.76M |
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$24.6M |
| 2 |
Holocene Advisors
New York
|
-$22.8M |
| 3 |
ESCM
Echo Street Capital Management
New York
|
-$15.7M |
| 4 |
CCA
Conestoga Capital Advisors
Wayne,
Pennsylvania
|
-$14.7M |
| 5 |
BlackRock
New York
|
-$4.8M |
DH Hedge Fund Activity: Q3 2022 in Review
123 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Definitive Healthcare (DH) for Q3 2022, worth a combined $1.69B — down 29% from $2.39B a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new DH positions and 20 closed out — a net gain of 8 holders — while 57 added to existing stakes and 26 trimmed.
The largest buyer was Fred Alger Management, adding an estimated $36.7M. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $24.6M sold.
- 123 institutional investors held Definitive Healthcare (DH) as of Q3 2022, up from 116 in Q2 2022.
- Funds reported $1.69B of Definitive Healthcare stock for Q3 2022, down 29% quarter-over-quarter.
- 28 funds opened new Definitive Healthcare positions in Q3 2022 and 20 closed out, a net change of +8 holders.
- The largest Definitive Healthcare buyer in Q3 2022 was Fred Alger Management, an estimated $36.7M added.
- The largest Definitive Healthcare seller in Q3 2022 was T. Rowe Price Associates, an estimated $24.6M sold.
Based on aggregated 13F filings for Q3 2022.